Lessee, Operating Lease, Liability, to be Paid in USD of Omega Therapeutics, Inc. from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Omega Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2021 to Q3 2024.
  • Omega Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2024 was $200M, a 2.61% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Omega Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $200M -$5.36M -2.61% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $197M +$14.3M +7.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $199M +$196M +8223% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $201M +$198M +7155% Dec 31, 2023 10-K 2024-03-28
Q3 2023 $205M +$202M +6410% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $183M +$179M +4852% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.39M -$2.17M -47.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.77M -$193M -98.6% Dec 31, 2022 10-K 2023-03-01
Q3 2022 $3.15M -$3.08M -49.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $3.69M -$3.37M -47.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $4.56M Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $196M Dec 31, 2021 10-K 2022-03-10
Q3 2021 $6.23M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $7.06M Jun 30, 2021 10-Q 2021-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.